These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34294629)

  • 21. Improvements in both psychosis and motor signs in Parkinson's disease, and changes in regional cerebral blood flow after electroconvulsive therapy.
    Usui C; Hatta K; Doi N; Kubo S; Kamigaichi R; Nakanishi A; Nakamura H; Hattori N; Arai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1704-8. PubMed ID: 21605615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute Presentation of Nonmotor Symptoms in Parkinson's Disease.
    Kwei K; Frucht S
    Int Rev Neurobiol; 2017; 134():973-986. PubMed ID: 28805591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C; Planès S; Logerot S; Villier C; Mallaret M
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electroconvulsive therapy for depression in Parkinson's disease: systematic review of evidence and recommendations.
    Borisovskaya A; Bryson WC; Buchholz J; Samii A; Borson S
    Neurodegener Dis Manag; 2016 Apr; 6(2):161-76. PubMed ID: 27033556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electroconvulsive therapy (ECT) in Parkinson's disease: ECS and dopamine enhancement.
    Cumper SK; Ahle GM; Liebman LS; Kellner CH
    J ECT; 2014 Jun; 30(2):122-4. PubMed ID: 24810775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Depressive symptoms and motor condition in Parkinson's disease patients].
    Stella F; Bucken-Gobbi LT; Gobbi S; Sant'Ana-Simões C
    Rev Neurol; 2007 Nov 16-30; 45(10):594-8. PubMed ID: 18008264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Focus on Depression in Parkinson's Disease: A Delphi Consensus of Experts in Psychiatry, Neurology, and Geriatrics.
    Agüera-Ortiz L; García-Ramos R; Grandas Pérez FJ; López-Álvarez J; Montes Rodríguez JM; Olazarán Rodríguez FJ; Olivera Pueyo J; Pelegrín Valero C; Porta-Etessam J
    Parkinsons Dis; 2021; 2021():6621991. PubMed ID: 33628415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutamate receptor antagonists for neuroleptic malignant syndrome and akinetic hyperthermic parkinsonian crisis.
    Kornhuber J; Weller M; Riederer P
    J Neural Transm Park Dis Dement Sect; 1993; 6(1):63-72. PubMed ID: 8105799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electroconvulsive therapy in drug resistant neuroleptic malignant syndrome.
    Patel AL; Shaikh WA; Khobragade AK; Soni HG; Joshi AS; Sahastrabuddhe GS
    J Assoc Physicians India; 2008 Jan; 56():49-50. PubMed ID: 18472502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A successfully treated parkinsonian patient with neuroleptic malignant syndrome complicated by status epilepticus and disseminated intravascular coagulation].
    Osoegawa M; Motomura S; Yamanaka H; Tamura K; Miyoshi T
    Rinsho Shinkeigaku; 1999 Jun; 39(6):653-7. PubMed ID: 10502992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Marked improvement of psychotic symptoms after electroconvulsive therapy in Parkinson disease.
    Ueda S; Koyama K; Okubo Y
    J ECT; 2010 Jun; 26(2):111-5. PubMed ID: 20386461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of electroconvulsive therapy on mood, parkinsonism, and tardive dyskinesia in a depressed patient: ECT and dopamine systems.
    Holcomb HH; Sternberg DE; Heninger GR
    Biol Psychiatry; 1983 Aug; 18(8):865-73. PubMed ID: 6615944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parkinson's Disease Multimodal Complex Treatment improves motor symptoms, depression and quality of life.
    Scherbaum R; Hartelt E; Kinkel M; Gold R; Muhlack S; Tönges L
    J Neurol; 2020 Apr; 267(4):954-965. PubMed ID: 31797086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical phenotype of drug-naïve Parkinson's disease based on nonmotor symptoms.
    Lee HM; Lee SS; Kim M; Kang SH; Seo WK; Kim JH; Koh SB
    Arch Gerontol Geriatr; 2015; 61(3):517-22. PubMed ID: 26183203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A 73-year-old woman with familial Parkinson's disease].
    Takanashi M; Urabe T; Ohta S; Hamano Y; Mori H; Shirai T; Kondo T; Mizuno Y
    No To Shinkei; 1999 Dec; 51(12):1087-96. PubMed ID: 10654309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Amantadine Withdrawal in 3 Cases of Treatment-Refractory Altered Mental Status.
    Fryml LD; Williams KR; Pelic CG; Fox J; Sahlem G; Robert S; Revuelta GJ; Short EB
    J Psychiatr Pract; 2017 May; 23(3):191-199. PubMed ID: 28492457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Parkinson's disease. Psychological disorders: striking a balance in order to optimise antiparkinsonian treatment.
    Prescrire Int; 2011 Oct; 20(120):242-5. PubMed ID: 21970092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.
    Thobois S; Ardouin C; Lhommée E; Klinger H; Lagrange C; Xie J; Fraix V; Coelho Braga MC; Hassani R; Kistner A; Juphard A; Seigneuret E; Chabardes S; Mertens P; Polo G; Reilhac A; Costes N; LeBars D; Savasta M; Tremblay L; Quesada JL; Bosson JL; Benabid AL; Broussolle E; Pollak P; Krack P
    Brain; 2010 Apr; 133(Pt 4):1111-27. PubMed ID: 20237128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical alterations during medication withdrawal in Parkinson's disease with and without neuroleptic malignant-like syndrome.
    Ueda M; Hamamoto M; Nagayama H; Okubo S; Amemiya S; Katayama Y
    J Neurol Neurosurg Psychiatry; 2001 Jul; 71(1):111-3. PubMed ID: 11413275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) with disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease].
    Yamawaki Y; Ogawa N
    Rinsho Shinkeigaku; 1991 Jan; 31(1):62-7. PubMed ID: 2044308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.